Abstract
There is now convincing evidence that it is possible to regularly cure certain experimental leukemias by using chemotherapeutic schedules specifically designed to exploit known information about the kinetic behavior of the leukemic cells, whereas other treatment schedules employing the same or higher total doses of the same drugs fail to effect any cures [1–9]. Much greater difficulty is encountered in treating spontaneous animal leukemias and human leukemia effectively, and the present paper is concerned with what we believe are the main reasons for these different results. To help focus attention on some of the critical points, two representative studies in patients with acute leukemia will be described for illustrative purposes, and general conclusions drawn from these studies in the context of previous information.
This investigation was supported in part by research grants CA-05826 and CA-08748 from the National Cancer Institute, United States Public Health Service, the American Cancer Society, T-538A, The John C. McCarroll Memorial Fund, Hearst Foundation Fund, United Leukemia Fund, and the Junior Committee of the Society of Memorial Sloan-Kettering Cancer Center.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Skipper, H. E., Schabel, F. M., Ja., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemother. Rep. 35, 1 (1964).
Schabel, F. M., Jr., Skipper, H. E., Trader, M. W., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. XIX. Sensitivity of non-dividing leukemic cell populations to certain classes of drugs in vivo. Cancer Chemother. Rep. 48, 17 (1965).
Kline, I., Venditti, J. M., Tyrer, D. R., Goldin, A.: Chemotherapy of leukemia L 1210 in mice with 1-ß-D-arabinofuranosylcytosine hydrochloride. I. Influence of treatment schedule. Cancer Res. 26, 853 (1966).
Skipper, H. E., Schabel, F. M., Jr., Wilcox, W. S.: Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells. Cancer Chemother. Rep. 51, 125 (1967).
Tyrer, D. D., Kline, I., Venditti, J. M., Goldin, A.: Separate and sequential chemotherapy of mouse leukemia L 1210 with 1-ß-D-arabinofuranosylcytosine hydrochloride and 1,3-bis (2-chloroethyl)-1-nitrosourea. Cancer Res. 27, 873 (1967).
Wheeler, G. P., Bowdon, B. J., Wilkoff, L. J., Dulmadge, E. A.: The cell cycle of leukemia L 1210 cells in vivo and in vitro. Proc. Soc. exp. Biol. (N. Y.) 126, 903 (1967).
Yankee, R. A., de Vita, V. T., Perry, S.: The cell cycle of leukemia L 1210 cells in vivo. Cancer Res. 27, 2381 (1967).
Skipper, H. E.: Cellular kinetics associated with “curability” of experimental leukemias. In: Perspectives in Leukemia. Eds.: W. Dameshek and R. M. Dutcher. New York-London: Grune & Stratton, p. 187, 1968.
Schabel, F. M., JR.: In vivo leukemic cell kill kinetics and “curability” in experimental systems. In: The Proliferation and Spread of Neoplastic Cells. Baltimore: Williams and Wilkins, p. 379 (1968).
Clarkson, B., Fried, J., Strife, A., Sakai, Y., Ota, K., Ohkita, T.: Studies of cellular proliferation in human leukemia. III. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for eight to ten days. Cancer 25, 1237 (1970).
Clarkson, B. D., Ohkita, T., Ota, K., Fried, J.: Studies of cellular proliferation in human leukemia. I. Estimation of growth rates of leukemic and normal hematopoietic cells in two adults with acute leukemia given single injections of tritiated thymidine. J. clin. Invest. 46, 506 (1967).
Fried, J.: Estimating the median generation time of proliferating cell systems in steady state. Biophys. J. 8, 710 (1968).
Clarkson, B. D., Fried, J., Strife, A., Sakai, Y., Ota, K., Ohkita, T., Masuda, R.: Studies of cellular proliferation in human leukemia. IV. Behavior of normal hematopoietic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine. Cancer 26, 1 (1970).
Fried, J.: Mean, geometric mean, or median grain count in cell cycle studies. Exp. Cell Res. 59, 447 (1970).
Philips, F. S., Sternberg, S. S., Schwartz, H. S., Cronin, A. P., Sodergren, J. E., Vidal, P. M.: Hydroxyurea I. Acute cell death in proliferating tissues in rats. Cancer Res. 27, 61 (1967).
Nery, R.: The colorimetric determination of hydroxamic acids. The Analyst, the Journal of the Society for Analytical Chemistry 91, 388 (1966).
Clarkson, B. D., Sakai, Y., Kimura, T., Ohkita, T., Fried, J.: Studies of cellular proliferation in human leukemia. II. Variability in rates of growth and cellular differentiation in acute myelomonoblastic leukemia and effects of treatment. In: The Proliferation and Spread of Neoplastic Cells. Baltimore: Williams and Wilkins Co. 1968, p. 295.
Fried, J., Ogawa, M.: Magnitude of proliferating fraction and rate of proliferation of populations of leukemic cells in man. Monograph: Symposium on normal and malignant cell growth. In: Recent Results in Cancer Research, Vol. 17. New York: Springer 1969, p. 175.
Gee, T. S., Yu, K.-P., Clarkson, B. D.: Treatment of adult acute leukemia with arabinosylcytosine and thioguanine. Cancer 23, 1019 (1969).
Clarkson, B., Krakoff, I., Burchenal, J., Karnofsky, D., Golbey, R., Oettgen, H., Dowling, M., Lipton, A.: Clinical results of treatment with E. coli L-asparaginase in adults with leukemia, lymphoma, and solid tumors. Cancer 25, 279 (1970).
Ota, K., Clarkson, B. D.: Unpublished observations.
Feinendegen, L. E., Odartchenko, N., Cottier, H., Bond, V. P.: Kinetics of megacaryocyte proliferation. Proc. Soc. exp. Biol. (N. Y.) 111, 177 (1962).
Ebbe, S., Stohlman, F., Jr.: Megakaryocytopoiesis in the rat. Blood 26, 20 (1965).
Odell, T. T., Jackson, C. W.: Polyploidy and maturation of rat megakaryocytes. Blood 32, 102 (1968).
Mendelsohn, M. L.: Autoradiographic analysis of cell proliferation in spontaneous breast cancer of C3H Mouse. III. The Growth Fraction. J. nat. Cancer Inst. 28, 1015 (1962).
Skipper, H. E.: Personal communication.
Gee, T. S., Todo, A., Strife, A., Clarkson, B. D.: Effect of Hydroxyurea (HU) and arabinosylcytosine (Ara-C) on logarithmic (log) and stationary (stat) phase human lymphoid (SK-L7) cells in vitro. Proc. Amer. Ass. Cancer Res. 11, 114 (1970).
Killmann, S.: Acute leukemia: the kinetics of leukemic blast cells in man. An analytical review. Ser. Haemat. 1, 38 (1968).
Ota, K.: Kinetics of cellular proliferation in leukemia and cancer. Acta Haemat. Jap. 27, 693 (1964).
Saunders, E. F., Lampkin, B. C., Mauer, A. M.: Variation of proliferative activity in leukemic cell populations of patients with acute leukemia. J. clin. Invest. 46, 1356 (1967).
Todo, A.: Proliferation and differentiation of hematopoietic cells in hematologic disorders. III. In vivo radioautographic study of leukemia including erythro-leukemia. Acta Haemat. Jap. 31, 947–966 (1968).
Stryckmans, P. A., Cronkite, E. P., Fache, J., Fliedner, T. M., Ramos, J.: DNA synthesis time of erythropoietic and granulopoietic cells in human beings. Nature 211, 717 (1966).
Gavosto, F., Pileri, A., Gabutti, V., Masera, P.: Cell population kinetics in human acute leukemia. Europ. J. Cancer 3, 301 (1967).
Keiser, G., Wagner, H. P., Frey-Wettstein, M.: Cytokinetic studies in two acute lymphoblastic leukemias. Heiv. med. Acta 34, 155 (1968).
Mauer, A. M., Fischer, V.: Characteristics of cell proliferation in four patients with untreated acute leukemia. Blood 28, 428 (1966).
Lala, P. K., Maloney, M. A., Patt, H. M.: Measurement of DNA-synthesis time in myeloid-erythroid precursors. Exp. Cell Res. 38, 626 (1965).
Clarkson, B., Ohkita, T., Ota, K., O’connor, A.: Studies of cellular proliferation in acute leukemia. J. clin. Invest. (abstract) 44, 1035 (1965).
Ogawa, M.: Studies of cellular proliferation in acute leukemia using H3-thymidine. Nagoya Med. Assoc. J. 90, 91 (1967).
Clarkson, B. D.: Review of recent studies of cellular proliferation in acute leukemia. In: Human Tumor Cell Kinetics. Ed.: S. Perry. Bethesda (Md.): National Cancer Institute (Monograph No. 30), p. 81 (1969).
Fried, J.: A proposal for the determination of generation time variability and dormancy of proliferating cell populations by a modification of the grain count halving method. (Submitted to J. theor. Biol.)
Tono, A., Fried, J., Clarkson, B.: Kinetics of proliferation of human hematopoietic cells in suspension culture. Proc. Amer. Ass. Cancer Res. 10, 93 (1969).
Schmid, J. R., Oechslin, R. J., Frick, P. G., Moeschlin, S.: Cell proliferation in leukemia during relapse and remission. II. DNA synthesis of leukemic cells in the peripheral blood in vitro. Acta Haemat. (Basel) 37, 16 (1967).
Pileri, A., Gabutti, V., Masera, P., Gavosto, F.: Proliferative activity of the cells of acute leukemia in relapse and in steady state. Acta Haemat. (Basel) 38, 193 (1967).
Foadi, M. D., Cooper, E. H., Hardisty, R. M.: Proliferative activity of leukemic cells at various stages of acute leukemia of childhood. Brit. J. Haemat. 15, 269 (1968).
B. Clarkson et al.: Consideration of the Cell Cycle in Chemotherapy of Acute Leukemia
Frei, E., III, Freireich, E. J.: Progress and perspectives in the chemotherapy of acute leukemia. In: Advances in Chemotherapy. Eds.: A. Goldin, F. Hawking, and R. J. Schnitzer. New York: Academic Press 1965, p. 269.
Clarkson, B. D.: Clinical techniques for evaluating antileukemic efficacy. In: Animal and Clinical Pharmacologic Techniques in Drug Evaluation, Vol. 2. Eds.: P. E. Siegler, and J. H. Moyer, III. Chicago: Year Book Med. Publ. Inc. 1967, p. 836.
Bodey, G. P., Freireich, E. J., Monto, R. W., Hewlett, J. S.: Cytosine arabinoside (NSC-63878) therapy for acute leukemia in adults. Cancer Chemother. Rep. 53, 59 (1969).
Henderson, E. S.: Treatment of acute leukemia. Seminars in Hematology 6, 271 (1969).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Clarkson, B., Todo, A., Ogawa, M., Gee, T., Fried, J. (1971). Consideration of the Cell Cycle in Chemotherapy of Acute Leukemia. In: Ultmann, J.E., Griem, M.L., Kirsten, W.H., Wissler, R.W. (eds) Current Concepts in the Management of Lymphoma and Leukemia. Recent Results in Cancer Research, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46259-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-46259-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46261-0
Online ISBN: 978-3-642-46259-7
eBook Packages: Springer Book Archive